Metabolic and vascular effect of progestins in post-menopausal women - Implications for cardioprotection

被引：26

作者：

Rosano, GMC ^{[1
]}

Vitale, C ^{[1
]}

Silvestri, A ^{[1
]}

Fini, M ^{[1
]}

机构：

[1] Tosinvest Sanita, Dept Internal Med, Cardiovasc Res Unit, I-00168 Rome, Italy

来源：

MATURITAS | 2003年 / 46卷

关键词：

metabolic and vascular effect; progestins; cardioprotection; hormone replacement therapy; endothelial function; diabetes;

D O I：

10.1016/j.maturitas.2003.09.015

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Estrogen therapy causes changes in a variety of cardiovascular risk factors, including insulin resistance, lipoprotein profile, haemostasis, coronary atherosclerosis and vascular reactive, that suggest a potential cardioprotective effect in postmenopausal women. With respect to the role of adjunctive progestins, currently available data suggest that the cardiovascular effects may differ depending on the type, dosage and route of administration of the progestin. Androgenic progestins antagonise the favourable cardiovascular effect of estrogens, whilst non-androgenic progestins do not impair, or may even enhance, the beneficial effect of estrogens. Therefore, less androgenic progestins would appear to be the agent of choice for combined hormone therapy in postmenopausal women with cardiovascular risk factors. (C) 2003 Published by Elsevier Ireland Ltd.

引用

页码：S17 / S29

页数：13

共 56 条

[51] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].

Rossouw, JE ;

Anderson, GL ;

Prentice, RL ;

LaCroix, AZ ;

Kooperberg, C ;

Stefanick, ML ;

Jackson, RD ;

Beresford, SAA ;

Howard, BV ;

Johnson, KC ;

Kotchen, JM ;

Ockene, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333

[52] The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease [J].

Sbarouni, E ;

Kyriakides, ZS ;

Kremastinos, DT .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1244-1250

[53] HEMOSTATIC CHANGES DURING CONTINUOUS ESTRADIOL-PROGESTOGEN TREATMENT OF POSTMENOPAUSAL WOMEN [J].

SPORRONG, T ;

MATTSSON, LA ;

SAMSIOE, G ;

STIGENDAL, L ;

HELLGREN, M .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (10) :939-944

[54] Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease [J].

Vitale, C ;

Fini, M ;

Leonardo, F ;

Rossini, P ;

Cerquetani, E ;

Onorati, D ;

Rosano, GMC .

MATURITAS, 2001, 40 (03) :239-245

[55] EFFECTS OF HORMONE REPLACEMENT THERAPY ON REACTIVITY OF ATHEROSCLEROTIC CORONARY-ARTERIES IN CYNOMOLGUS MONKEYS [J].

WILLIAMS, JK ;

HONORE, EK ;

WASHBURN, SA ;

CLARKSON, TB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (07) :1757-1761

[56] Prediction of coronary heart disease using risk factor categories [J].

Wilson, PWF ;

D'Agostino, RB ;

Levy, D ;

Belanger, AM ;

Silbershatz, H ;

Kannel, WB .

CIRCULATION, 1998, 97 (18) :1837-1847

← 1 2 3 4 5 6 →